文献速递骨质疏松与钙磷/甲状旁腺垂体与肾上腺疾病

DHEAS对骨量与骨折风险年龄相关变化中的保护作用

Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究采用孟德尔随机化分析,利用与血清硫酸脱氢表雄酮(DHEAS)浓度相关的单核苷酸多态性作为工具变量,探讨DHEAS在骨密度(BMD)和骨折风险年龄相关变化中的作用。结果显示,血清DHEAS浓度每增加一个对数转换单位(µmol/L),跟骨估计BMD增加0.120个标准差(95%CI 0.081-0.158,P=9×10⁻¹⁰),骨折风险降低(OR 0.989,95%CI 0.981-0.996,P=0.005),且该关联在调整身高、BMI、睾酮、雌二醇、性激素结合球蛋白和胰岛素样生长因子1后仍存在。DHEAS与BMD的关联仅在男性中观察到。

要点

  • DHEAS升高与跟骨、股骨颈和腰椎BMD增加相关。
  • DHEAS升高与骨折风险降低相关,BMD是主要中介因素。
  • DHEAS与BMD的关联在男性中显著,女性中未观察到。

核心结论

  • DHEAS与BMD增加和骨折风险降低相关,可能通过增加骨量发挥保护作用。
  • DHEAS与BMD的关联在男性中存在,在女性中未观察到。

研究设计与样本

  • 采用孟德尔随机化分析,以血清DHEAS相关SNP为工具变量(主分析4个SNP;性别分析男性4个、女性5个)。
  • 汇总统计量来自相关全基因组关联研究。

主要发现

  • 血清DHEAS每增加一个对数转换单位(µmol/L),跟骨估计BMD增加0.120个标准差(95%CI 0.081-0.158,P=9×10⁻¹⁰)。
  • 血清DHEAS每增加一个对数转换单位(µmol/L),骨折风险降低(OR 0.989,95%CI 0.981-0.996,P=0.005)。
  • 调整身高、BMI、睾酮、雌二醇、性激素结合球蛋白和胰岛素样生长因子1后,关联仍存在。
  • 调整跌倒、握力和体力活动后,DHEAS与骨折的关联仍存在,但调整BMD后减弱。
  • MR-Bayesian模型平均分析显示BMD是DHEAS与骨折关联的首要中介因素。

临床怎么用

  • DHEAS可能作为评估年龄相关骨量下降和骨折风险的参考指标。
  • 在男性中,DHEAS与BMD的关联更显著,临床关注男性骨健康时可考虑DHEAS水平。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dehydroepiandrosterone sulfate (DHEAS) from the adrenal cortex substantially decreases with age, which may accelerate osteoporosis. However, the association of DHEAS with bone mineral density (BMD) and fracture is inconclusive. We conducted a Mendelian randomization (MR) analysis to investigate the role of DHEAS in age-related changes in BMD and fracture risk. METHODS: Single nucleotide polymorphisms (SNPs) associated with serum DHEAS concentrations were used as instrumental variables (4 SNPs for main analysis; 4 SNPs for men and 5 SNPs for women in sex-related analysis). Summary statistics were obtained from relevant genome-wide association studies. RESULTS: A log-transformed unit (µmol/L) increase in serum DHEAS concentrations was associated with an SD increase in estimated BMD at the heel (estimate, 0.120; 95% CI, 0.081-0.158; P = 9 × 10-10), and decreased fracture (odds ratio, 0.989; 95% CI, 0.981-0.996; P = 0.005), consistent with dual-energy X-ray absorptiometry-derived BMD at the femoral neck and lumbar spine. Their associations remained even after adjusting for height, body mass index, testosterone, estradiol, sex hormone-binding globulin, and insulin-like growth factor 1. The association of DHEAS with fracture remained after adjusting for falls, grip strength, and physical activity but was attenuated after adjusting for BMD. The MR-Bayesian model averaging analysis showed BMD was the top mediating factor for association of DHEAS with fracture. The association between DHEAS and BMD was observed in men but not in women. CONCLUSION: DHEAS was associated with increased BMD and decreased fracture. DHEAS may play a protective role in decreasing fracture risk, mainly by increasing bone mass.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yokomoto-Umakoshi M, Umakoshi H, Iwahashi N, et al. Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk. J Clin Endocrinol Metab. 2021. PMID: 34415029. doi:10.1210/clinem/dgab459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。